Behbahani Ali 4

What Happened
Ali Behbahani, a member of Korro Bio's board of directors, received a grant of 14,677 derivative shares on June 10, 2026. The award is reported at $0.00 per share (total reported value $0) and is recorded as a derivative award (transaction code A). This is an equity award to a non-employee director (routine compensation), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-10; Form 4 filed 2026-06-11 (timely filing).
• Transaction type/code: Grant/Award (A), derivative securities, $0.00 per share.
• Shares granted: 14,677 derivative shares. Reported total value: $0.
• Vesting: Per footnote F1, the award vests in full on the earlier of (i) one-year anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service as a non-employee director.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• No exercise, sale, or tax-withholding transaction reported in this filing.

Context
This appears to be a standard equity grant for a non-employee director as part of board compensation. Derivative awards at $0 typically represent restricted equity or similar awards subject to vesting; they do not involve an immediate cash outlay or sale. Such grants are common and do not by themselves indicate insider buying or selling sentiment.